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Over  the last  decades,  developments  in the fields  of genetics  and  bioinformatics
caused  a marked  increase  in the processing  of human  genetic  data  by various
companies  and institutions.  This  results  in the adoption  of several  international
documents  and  the emergence  of legal  norms  on the protection  of genetic  data.
The paper  examines  how and to what  extent  the interests  and rights  of the data
subject with regard to the processing of genetic data are protected in the European
Union.  It  is  concluded that  under  the GDPR this  task  is  implemented through
classifying  genetic  data  as sensitive,  reliance  on anonymisation  and
pseudonymisation,  as well  as introduction  of the procedure  of data  protection
impact assessment.  Nevertheless,  given the unique characteristics of genetic  data
distinguishing them from other categories of personal data, these measures cannot
be  regarded  as sufficient  and  effective.  The paper  argues  that  current  EU data
protection  legislation  creates  favourable  conditions  for  genetic  research,  thereby
ensuring particular  public  interests,  but  does  not  establish  a special  regime  for
genetic  data  processing  appropriate  to potential  threats  in this  field  and  risks
to the rights of data subjects.
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1. INTRODUCTION
The emergence  at the national  and  international  levels  of legal  rules
protecting  the rights  of natural  persons  regarding  the processing  of their
personal  data  is  both  a direct  consequence  of the rapid  development
of information  technology in the second half  of the twentieth century and
an attempt  to respond  appropriately  to the threats  posed  by it.  However,
science  does  not  stand  still  and  the information  revolution  we  are
witnessing  is  probably  far  from  over.  In this  regard,  the legislative  and
other  public  authorities  are  forced  to constantly  respond  to the changing
environment in which personal data protection rules adopted by them must
be  applied.  This  is  not  an easy  task,  as they  have  to act  in the face
of uncertainty  of many  factors  and  to balance  between  the various  vital
public and private interests, none of which can be ignored.1
The European  Union  is  recognized  as the world’s  leader  in creating
advanced  standards  of personal  data  protection.  The new  General  Data
Protection  Regulation  2016/6792 (hereinafter  referred  to  as the “GDPR”)
adopted by it in 2016, which came into force in 2018, replacing the former
Directive 95/46/EC3, is precisely such an attempt to respond to the challenges
of the time  and  to create  a solid  foundation  for  the protection  of various
private  and  public  interests  in this  field.  One  of the innovations
of the GDPR  is  the provisions  concerning  human  genetic  data
the processing of which has radically  increased in recent  years.4 This  fact
has  not  been  overlooked  by other  international  organizations  concerned
with issues such as development of science  and personal data protection.
1 Borry, P. et al. (2018) The Challenges of the Expanded Availability of Genomic Information:
An Agenda-Setting Paper. The Journal of Community Genetics, 9 (2), pp. 103–116.
2 Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016
on the protection  of natural  persons  with  regard  to the processing  of personal  data  and
on the free  movement  of such  data,  and  repealing  Directive  95/46/EC  (General  Data
Protection Regulation). Official Journal of the European Union (2016/L-119/1) 4 May. Available
from:  https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679&from=
EN [Accessed 7 March 2020].
3 Directive  95/46/EC  of the European  Parliament  and  of the Council  of 24  October  1995
on the protection  of individuals  with  regard  to the processing  of personal  data  and
on the free  movement  of such  data.  Official  Journal  of the European  Communities  (1995/L-
-281/31) 23 November. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF
/?uri=CELEX:31995L0046&from=en [Accessed 7 March 2020].
4 For instance,  according to Regalado,  by 2019 more than 26 million consumers had added
their  DNA  to four  leading  commercial  databases.  If this  trend  continues,  this  figure  is
expected to rise to 100 million within 24 months. Regalado, A. (2019) More than 26 million
people have taken an at-home ancestry test. MIT Technology Review. [online] Available from:
https://www.technologyreview.com/s/612880/more-than-26-million-people-have-taken-an-
at-home-ancestry-test/ [Accessed 7 March 2020].
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In particular,  in 2003,  the General  Conference  of UNESCO  adopted
a landmark document entitled the International Declaration on Human Genetic
Data. Even earlier, in 1997, the Committee of Ministers of the Council of Europe
adopted  the Recommendation  R (97) 5  on the Protection  of Medical  Data,
containing much reference to genetic data. In 2018, the provision on genetic
data was added to the Convention for the Protection of Individuals with regard
to Automatic Processing of Personal Data (ETS. No. 108) through the adoption
of the Protocol (CETS No. 223) amending the Convention.
Although  the protection  of genetic  information  derived  from  human
tissue  is  not  yet  the subject  of special  interest  of a wide  range  of legal
scholars,  it  is  still  an important  issue for detailed examination because  it
opens  up  entirely  new  problems  and  makes  one  think  about
the perspectives  of the whole  contemporary  system  of personal  data
protection. In such a case of conflict between two important interests, it is
difficult  to reconcile  them  in order  to achieve  a stable  and  harmonious
balance. On the one hand, there are interests of individuals whose genetic
data  are  processed,  as well  as significant  public  interests  related
to the control over extremely powerful technologies and the specific  ways
they are applied. On the other hand, there are equally important interests
related to conducting  research  in the fields  of genetics  and bioinformatics
that  are  crucial  for  overcoming  certain  urgent  problems  of humanity.
Accordingly,  there  exist  legitimate  expectations  of society  for  an increase
of scientific knowledge, which are highlighted in the GDPR.5
Taking all these things into consideration, our main task is to investigate
how  and  to what  extent  these  interests  are  protected  in the current  EU
legislation. In particular, we tried to find out whether the level of protection
of natural  persons  with  regard  to the processing  of their  genetic  data
increases  over  time  and  whether  it  responds  to the current  realities  and
challenges posed by the rapid development of science and technology. 
Over  the last  three  decades,  interrelated  issues  such  as the legal
protection of human genetic data, the maintenance of genetic privacy, and
the prevention of genetic discrimination have repeatedly attracted attention
of researchers from various scientific disciplines. Among the scholars who
made  a significant  contribution  to research  in this  field  are  P.  Billings,
L. Bygrave, M. Gerstein, L. Gostin, Y. Erlich, B. Korf, T. Lemke, M. Taylor. Since
5 See Recital 113 of the GDPR.
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the GDPR  was  adopted,  a number  of academic  works  (in particular,
by P. Borry, A. de Paor, K. Pormeister, M. Shabani, L. Quinn, P. Quinn) directly
related  to the processing  of personal  genetic  data  under  the current  EU
legislation have been presented.
2. GENETIC DATA AS A SPECIAL CATEGORY 
OF PERSONAL DATA
The GDPR contains several provisions concerning genetic data and the risks
associated  with  their  processing.  Besides,  the very  definition  of personal
data  is  supplemented  by a reference  to genetic  factors  as one
of the identifiers  of a natural  person.6 In contrast,  genetic  data
or characteristics  are  not  mentioned  in the Directive  95/46/EC  at all.
However,  this  does  not  mean  that  at the time  when  the Directive  was
in force,  such  data  did  not  fall  under  the EU  legislation  or was  not
considered  as personal  data.  In its  documents  the Working  Party
on the protection  of individuals  with  regard  to the processing  of personal  data –
an advisory body established under Article 29 of the Directive (hereinafter
referred  to  as the Article  29  Working  Party)  made  repeated  references
to the issues related to genetic data and highlighted the need to ensure that
they are properly handled. This matter is even addressed by a separate act
of the Working Party  entitled the Working Document on Genetic Data,  which
was  adopted  in 2004.7 It  is  of special  significance  for  us  as it  makes  it
possible to compare the EU’s genetic data protection policy before and after
the adoption of the GDPR.
The threats  associated  with  the processing  of genetic  data  are  briefly
mentioned  in the GDPR.  In particular,  Recitals  71  and  75  outline
the potential  risks  and possible  discriminatory  effects  on natural  persons
on the basis  of genetic  or health  status.  However,  it  is  doubtful  whether
these  provisions  provide  a comprehensive  and  detailed  picture
of the threats in this field. For comparison, this issue is covered in greater
detail in the Working Document of the Article 29 Working Party. It provides,
inter alia, the following characteristics of genetic data distinguishing it from
other categories of data and causing the necessity of greater protection:
6 See Article 4 (1) of the GDPR.
7 According  to Article  30  of the Directive  95/46/EC,  the Working  Party  is  authorised
to examine any question covering the application of the national measures adopted under
the Directive  and  to advise  on all  matters  relating  to the protection  of individuals  with
regard to the processing of personal data, as well as to perform other functions.
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(1) genetic  data reveal  information not only about the data subject,
but  also  about  his  or her  blood  relatives  and  certain  groups
of persons to which he or she belongs;
(2) as a rule,  genetic  information  is  unknown  to the bearer
him/herself  and does not depend on the bearer’s individual will
since genetic data are non-modifiable;
(3) genetic data can be easily obtained from raw materials;
(4) genetic  data  may  reveal  more  information  in the future  and  be
used by an increasing number of agencies for various purposes.8
The document  also  mentions  the risks  of genetic  data  re-use  that  might
occur,  inter alia,  through additional  analysis of stored biological  materials
and  provides  detailed  information  on threats  of using  such  data  for
the purposes  connected  with  employment,9 insurance,  identification,
medical  and  scientific  research.  Besides,  the Article  29  Working  Party
highlights
“the present  absence  of regulatory  framework  in the field  of the on-line
‘genetic testing direct to the public’”.10
According to the GDPR, genetic data means
“personal  data  relating  to the inherited or acquired genetic  characteristics
of a natural  person  which  give  unique  information  about  the physiology
or the health  of that  natural  person  and which  result,  in particular,  from
an analysis of a biological sample from the natural person in question”.11
8 Article  29  Data  Protection  Working  Party.  (2004)  Working  Document  on Genetic  Data,
12178/03/EN WP 91, 17 March, pp. 4–5. Available from: https://ec.europa.eu/justice/article-
29/documentation/opinion-recommendation/files/2004/wp91_en.pdf  [Accessed  9  March
2020].
9 As for  employment,  the draft  Regulation,  adopted  by Parliament at the first  reading,
stipulated  that  data  collection  for  the purpose  of genetic  testing  and  analyses  shall  be
prohibited  in this  field  as a matter  of principle.  However,  the relevant  article  was  later
removed.  European Parliament legislative resolution of 12 March 2014 on the proposal for
a regulation of the European Parliament and of the Council on the protection of individuals
with  regard  to the processing  of personal  data  and  on the free  movement  of such  data
(General Data Protection Regulation). Official Journal of the European Union (2017/C- 378/399)
9 November, Article 82 (c). Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/
PDF/?uri=CELEX:52014AP0212&from=EN [Accessed 7 March 2020].
10 Article  29  Data  Protection  Working  Party.  (2004)  Working  Document  on Genetic  Data,
12178/03/EN  WP  91,  17  March,  pp. 13–14.  Available  from:  https://ec.europa.eu/justice/
article-29/documentation/opinion-recommendation/files/2004/wp91_en.pdf  
[Accessed 9 March 2020].
11 See Article 4 (13) of the GDPR.
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It should be noted that in the draft Regulation, submitted by the European
Commission in 2012, genetic data are defined in a different way as
“all  data,  of whatever  type,  concerning the characteristics of an individual
which are inherited or acquired during early prenatal development”.12
The Working  Document  of the Article  29  Working  Party  sets  out  various
definitions  of genetic  data  which  are  taken  from  the Council  of Europe
Recommendation R (97) 5, Law of Luxembourg on the protection of persons
with  regard  to the processing  of personal  data,  and  the International
Declaration  on Human Genetic  Data  adopted by UNESCO.13 However,  only
in the last document as well as in the GDPR interpretation of genetic data is
linked to the analysis  of biological  materials  which  should be  carried out
to obtain such data. This approach has been criticized by some researchers.
In particular,  Shabani  and  Borry  consider  this  issue  problematic  because
of the activities  of DNA  testing,  medical,  and  other  companies  that  use
genealogical data gathered through both genetic investigation and various
questionnaires  filled  out  by their  clients.14 In addition,  other  factors  like
phenotypic  characteristics  may  indicate  some  features  of the personal
genome.  Taylor  rightly points out that such information is far from being
precise  but  this  does  not  mean  we  can  ignore  its  significance  as well
as potential harm caused by the improper use of such data.15
Such  a narrow  interpretation  of genetic  data  is  not  fully  justified,
especially if taking primarily into account the interests of the data subject.16
It  is  not  excluded  that  in the future  this  definition  can  cause  additional
difficulties  in the protection  of individual’s  rights  as he/she  will  have
12 European  Commission.  (2012)  Proposal  for  a Regulation  of the European  Parliament  and
of the Council  on the protection  of individuals  with  regard  to the processing  of personal  data  and
on the free  movement  of such data (General Data Protection Regulation),  COM/2012/011 final –
2012/0011 (COD), 25 January, Article 4 (10). Available from: https://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:52012PC0011&from=EN [Accessed 9 March 2020].
13 Article  29  Data  Protection  Working  Party.  (2004)  Working  Document  on Genetic  Data,
12178/03/EN WP 91, 17 March, p. 4. Available from: https://ec.europa.eu/justice/article-29/
documentation/opinion-recommendation/files/2004/wp91_en.pdf [Accessed 9 March 2020].
14 Shabani, M. and Borry, P. (2018) Rules for processing genetic data for research purposes
in view  of the new  EU  General  Data  Protection  Regulation.  European  Journal  of Human
Genetics, 26 (2), p. 152.
15 Taylor,  M.  (2012)  Genetic  Data  and  the Law:  A Critical  Perspective  on Privacy  Protection.
Cambridge: Cambridge University Press, p. 46.
16 See also: De Paor, A. (2017) The European Union and Protection of Genetic Information.
In: De  Paor,  A.  (ed.).  Genetics,  Disability  and  the Law:  Towards  an EU  Legal  Framework.
Cambridge:  Cambridge  University  Press  (Cambridge  Disability  Law and  Policy  Series),
p. 230.
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to prove that  personal genetic  data result  from an analysis  of a biological
sample. Otherwise, provided that it is not medical data, he may be deprived
of the rights guaranteed to the individual with regard to his personal data
classified as sensitive.  What is  even more surprising is  that the definition
of genetic data under the GDPR refers to the
“analysis of a biological sample from the natural person in question”, 
that is, samples of a particular person who is the data subject. If a biological
sample  is  taken  from  the blood  relative  of a particular  individual  (even
in a case if the probability that they both have the same gene is extremely
high),  the result  from  the analysis  of this  sample  will  not  be  considered
as this individual’s genetic data. Consequently, he or she will have no rights
related  to this  genetic  information.  In contrast,  the definition  of human
genetic data from the aforementioned UNESCO Declaration, which can be
considered as the most authoritative universal document in this field, only
mentions that such information has to be “obtained by analysis of nucleic acids
or by other  scientific  analysis” without  making  any reference  to a biological
material of a particular person.17
Thus, the GDPR does not take into account the considerations previously
mentioned  in the Working  Document,  namely  the fact  that  genetic  data
reveal  information  about  an individual’s  blood  relatives,  and  does  not
ensure the protection of the rights of such persons.18 The Article 29 Working
Party  was generally inclined to recognize some relatives’ rights regarding
the processing  of genetic  data  (but  without  classifying  them  as data
subjects) and noted the need for further study of this issue.19 To address this
problem,  Taylor  proposes  to classify  these  persons  as “secondary  data
subjects” and to clearly enshrine their rights.20 It should also be recalled that
the GDPR does not apply to deceased persons21 and this creates additional
risks for the aforementioned “secondary data subjects”, since in such a case
17 United  Nations  Educational,  Scientific  and  Cultural  Organization.  (2003)  International
Declaration on Human Genetic Data, SHS/BIO/04/1, 16 October, Article 2 (i). Available from:
http://portal.unesco.org/en/ev.php-URL_ID=17720&URL_DO=DO_TOPIC&URL_SECTION
=201.html [Accessed 9 March 2020].
18 Article  29  Data  Protection  Working  Party.  (2004)  Working  Document  on Genetic  Data,
12178/03/EN WP 91, 17 March, p. 4. Available from: https://ec.europa.eu/justice/article-29/
documentation/opinion-recommendation/files/2004/wp91_en.pdf [Accessed 9 March 2020].
19 Op. cit., pp. 8–9.
20 Taylor,  M.  (2012)  Genetic  Data  and  the Law:  A Critical  Perspective  on Privacy  Protection.
Cambridge: Cambridge University Press, pp. 104, 117.
21 See Recitals 27 and 158 of the GDPR.
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the data  is  not  protected  by personal  data  protection  law  at all  (unless
the member  states  have  adopted  the relevant  rules  in accordance  with
the provisions of Recital 27).
Another  important  aspect  is  the protection  of the rights  of natural
persons regarding their biological samples, which are the source of the bulk
of genetic  information  the acquisition  of which  becomes  more  easily  and
cheaply available. That is, the threat to the person stemmed from unlawful
handling of his or her biological samples could potentially be more serious
than the one  resulting  from illegal  processing  of fragmented  information
about  personal  genome.  Nevertheless,  in accordance  with  the established
principles  governing personal data protection,  the GDPR deals only with
the data  processing  and  the handling  of biological  samples  falls  outside
of its  scope.  In this  regard,  Taylor  proves  the fallacy  of the artificial
distinction  between  the categories  of interpreted  genetic  data  (resulting
from the analysis  of a biological  sample) and interpretable one (including
biological  samples),  especially  when  the ultimate  goal  of regulation  is
to effectively  protect  the privacy  of the individuals.22 In any  case,
the justification of a separate regulation for the handling of genetic samples
and  the processing  of data  derived  from  these  samples  is  questionable,
given  the fact  that  even  companies  collecting  and  using  a large  amount
of genetic information often consider both as personal data.23
One  of the key  accomplishments  of the GDPR  is  the clear  and
unambiguous  assignment  of genetic  data to special  categories  of personal
data.  This  imposes  additional  obligations  on data  controllers  and  is
designed  to guarantee  the interests  and  rights  of natural  persons.  Yet,
in the past,  the vast  majority  of genetic  data  was  already  classified
as personal  data  belonging  to special  categories,  namely  to health  data.
In this regard, the Working Document on Genetic Data states that genetic data
may reveal not only information on an individual’s health status, but also
his  or her  ethnic  origin  and,  therefore,  may  also  belong  to the category
of sensitive  data.  Besides,  the Working  Party drew  the general  conclusion
that considering the 
22 Taylor,  M.  (2012)  Genetic  Data  and  the Law:  A Critical  Perspective  on Privacy  Protection.
Cambridge: Cambridge University Press, pp. 158–165.
23 For instance, MyHeritage, one of the world’s largest genealogy research services companies,
in its privacy policy statement, which contains the list of personal data that are collected
and  processed,  places  DNA  samples,  DNA  Results,  and  DNA  Reports  in one  group.
MyHeritage.  (2019)  MyHeritage  Privacy  Policy.  [online]  Available  from:  https://www.my
heritage.com/privacy-policy [Accessed 9 March 2020].
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“extremely  singular  characteristics  of genetic  data  and  their  link
to information that may reveal the health condition or the ethnic origin, they
should be treated as particularly sensitive data”
within  the meaning  of the provisions  of Directive  95/46/EC  relating
to special categories of personal data.24 It is undeniable that classifying all
personal genetic data as belonging to special categories and distinguishing
them  as a separate  category  is  a step  forward  in ensuring  adequate
protection  of the rights  of individuals.  On the other  hand,  unlike
the Working Document, the GDPR does not recognize special characteristics
and  the exceptional  sensitivity  of genetic  data,  making  it  necessary
to introduce  special  rules  and  measures.  It  only  places  genetic  data
in the extensive  list  of special  categories  of personal  data,  along  with
political  opinions,  religious  or philosophical  beliefs,  trade  union
membership,  etc.  For  comparison,  in Convention  No. 108,  as amended
by the Additional  Protocol  of 2018,25 genetic  data  are  classified  as one  out
of the four  groups  of special  categories  of personal  data.  Moreover  it  is
listed first and, at least, is clearly separated from all other categories.26
3. SAFEGUARDS FOR THE RIGHTS OF THE DATA 
SUBJECT
Taking into account the provisions of the GDPR and other relevant official
documents,27 it  can  be  concluded that  the task  of guaranteeing  the rights
of individuals regarding the processing of their genetic data is implemented
under the EU legislation through:
(a) classifying such data as sensitive;
24 Article  29  Data  Protection  Working  Party.  (2004)  Working  Document  on Genetic  Data,
12178/03/EN WP 91, 17 March, p. 5. Available from: https://ec.europa.eu/justice/article-29/
documentation/opinion-recommendation/files/2004/wp91_en.pdf [Accessed 9 March 2020].
25 Council  of Europe.  (2018)  Convention  108+  (Modernised  Convention  for  the Protection
of Individuals with Regard to the Processing of Personal Data), 21 June, Article 6 (1). Available
from:  https://www.europarl.europa.eu/meetdocs/2014_2019/plmrep/COMMITTEES/LIBE/
DV/2018/09-10/Convention_108_EN.pdf [Accessed 7 March 2020].
26 It is worth noting that the lack of any other special provisions on genetic data in Convention
108+ at a time  when  the urgency  and  significance  of the matter  is  highlighted  in many
studies  and  genetic  data  processing  has  become  widespread  is,  obviously,  its  serious
drawback.
27 For example,  European Parliament.  Committee  on Petitions.  (2019)  Petition No 0733/2018
by J.B. (Portuguese) on improving the protection of genetic data related to European Union citizens,
15  March.  Available  from:  https://www.europarl.europa.eu/doceo/document/PETI-CM-
637225_EN.pdf [Accessed 7 March 2020].
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(b) introduction  of the procedure  of data  protection  impact
assessment;
(c) reliance on anonymisation and pseudonymisation of genetic data.
3.1. ADDITIONAL GUARANTEES REGARDING SENSITIVE DATA
Article  9  of the GDPR  relating  to the handling  of special  categories
of personal  data  defines  the legal  grounds  for  their  processing,
in the absence of which such data cannot be processed. Although the list is
extensive, given the specific nature of the use of genetic data, (1) the explicit
consent of the data subject and
(2)  “archiving  purposes  in the public  interest,  scientific  or historical
research purposes or statistical purposes in accordance with Article 89 (1)”28
can be considered as two main grounds for their processing which cover
the vast  majority  of cases.  Comparing  these  provisions  with
the corresponding  Article  8  of Directive  95/46/EC,  it  is  noticeable  that
the list of legal grounds for the processing of special categories of data has
been  significantly  broadened  and  supplemented,  inter  alia,
by the aforementioned  subparagraph  on scientific  research  purposes
relating directly to genetic data. 
Another important difference is that the Directive specifying a short list
of legal  grounds  enables  member  states  to expand  it  for  reasons
of substantial  public  interest.29 In contrast,  the GDPR  provides  a broader
range of grounds, but allows states to
“introduce  further  conditions,  including  limitations,  with  regard
to the processing of genetic data, biometric data or data concerning health”.30
In assessing both options from the perspective of the data subject, it can be
concluded that the new European standard established by the GDPR is less
favourable to an individual, especially given the conventionality of borders
when  it  comes  to scientific  research  or the Internet  service  industry.31
In realizing  their  right  to introduce  further  conditions  with  regard
to the processing  of genetic  data  member  states  are  limited  by other
28 See Article 9 (2) (a) and (j).
29 See Article 8 (4) and Recital 34 of Directive 95/46/EC.
30 See Article 9 (4) of the GDPR.
31 Pormeister, K. (2017) Genetic data and the research exemption: is the GDPR going too far?
International Data Privacy Law, 7 (2), p. 146.
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provisions of the GDPR. In particular, Recital 9 refers to the negative effects
of differences  in national  legislation  on personal  data  protection,  which
prevent  the free  flow  of data  and  constitute  an obstacle  to the pursuit
of economic activities at the level of the Union. In addition, Recital 10 makes
it clear that Article 9 (4) refers specifically to the possibility of introducing
“national  provisions to further specify  the application of the rules”  of the GDPR
and not to a substantial deviation from its certain provisions (for instance,
from those permitting the processing of genetic data for scientific research
purposes without the consent of the data subject). 
Other guarantees ensuring an adequate level of protection of the rights
of individuals with regard to the processing of special categories of personal
data,  which  are  provided  for  in the GDPR,  include  the prohibition
of automated  individual  decision-making  based  on such  data  (except
in cases when the data subject has given his or her explicit consent or it is
necessary  for  reasons  of substantial  public  interest)32 and  the obligation
of the controller  and  the processor  to designate  a data  protection  officer
in the case where their core activities consist of processing on a large scale
of special  categories  of data.33 The draft  Regulation  submitted  in 2012
comprised  another  important  provision  that  empowered  the European
Commission
“to adopt delegated acts [...] for the purpose of further specifying the criteria,
conditions  and  appropriate  safeguards  for  the processing  of the special
categories of personal data”.34
Obviously, such powers would make it possible to create uniform binding
and  detailed  standards  relating  to the processing  of genetic  data  within
the EU,  which  would  take  into  account  the specific  nature  of this  field.
However,  they,  like  most  of the other  powers  of the Commission to adopt
delegated acts  pursuant  to Article  92,  were excluded in the later  versions
of the draft Regulation. 
32 See Article 22 (4) of the GDPR.
33 See Article 37 (1) (c) of the GDPR.
34 European  Commission.  (2012)  Proposal  for  a Regulation  of the European  Parliament  and
of the Council  on the protection  of individuals  with  regard  to the processing  of personal  data  and
on the free  movement  of such data (General  Data Protection Regulation),  COM/2012/011 final –
2012/0011 (COD), 25 January, Article 9 (3). Available from: https://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:52012PC0011&from=EN [Accessed 9 March 2020].
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3.2. DATA PROTECTION IMPACT ASSESSMENT
The wording  of Recital  89  leads  to the conclusion  that  it  is  necessary
to apply different approaches to the protection of individuals when it comes
to the different  types  of personal  data.  In this  regard,  special  emphasis
should be placed on creating
“effective  procedures  and  mechanisms  which  focus  [...] on those  types
of processing operations which are likely to result in a high risk to the rights
and freedoms of natural persons”.35
One  of such  procedures  provided  for  in Recitals  90  and  91  is  a data
protection  impact  assessment,  the responsibility  for  which  in accordance
with  Recital  84  remains  with  the data  controller.  Article  35  of the GDPR
explicitly  states  that  an impact  assessment  is  required  in the case
of the “processing  on a large  scale  of special  categories  of data”.36 The grounds
and procedures of such assessment are described in detail in the Guidelines
on Data  Protection  Impact  Assessment  adopted  in 2017  by the Article  29
Working Party.37 This document explains,  inter alia, what factors need to be
taken  into  consideration  when  determining  whether  the processing  is
carried  out  on a large  scale.  The Guidelines  also  specifically  state  that
the activities of
“a biotechnology  company  offering  genetic  tests  directly  to consumers
in order to assess and predict the disease/health risks”
fall  under  the criteria  of “evaluation  or scoring,  including  profiling  and
predicting” [mentioned in Article 35 (3) of the GDPR] and, therefore, require
an impact assessment.38  Taking all  this into account, it can be concluded
that virtually all of the genetic data processing operations posing significant
risks to society should be covered by the data protection impact assessment.
However,  the feasibility  and  effectiveness  of this  assessment,  as well
as the objectivity  of its  results  are  quite  another  matter.  In this  regard,
Quinn  and  Quinn  point  out  that,  in the case  of the processing  of a large
35 See Recital 89 of the GDPR.
36 See Article 35 (3) (b) of the GDPR.
37 Article  29  Data  Protection  Working  Party.  (2017)  Guidelines  on Data  Protection  Impact
Assessment  (DPIA)  and  determining  whether  processing  is  “likely  to result  in a high  risk”  for
the purposes of Regulation 2016/679, 17/EN WP 248, 4 April. Available from: http://ec.europa.
eu/newsroom/document.cfm?doc_id=47711 [Accessed 9 March 2020].
38 Op. cit., p. 9.
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amount  of genetic  information,  even  a superficial  assessment  deals  with
a significant  number  of aspects.  The consideration of all  risks  to the rights
and  freedoms  of natural  persons  and the measures  envisaged  to address
the risks, as provided for in Article 35 of the GDPR,
“would  be  a potentially  enormous  exercise  demanding  a truly  multi-
-disciplinary perspective from disciplines such as ethics, law, genetics and
sociology”.39
All of this raises doubts as to whether each data controller would be able
to carry out such a procedure, whether the conclusions drawn up as a result
of it would be objective and impartial, and as to whether, in general, such
a mechanism is an effective way to safeguard the rights of natural persons
with regard to the processing of their genetic data.
3.3. ANONYMISATION AND PSEUDONYMISATION
The third  element  of the protection  of data  subjects’  rights  according
to the GDPR  is  the anonymisation  and  pseudonymisation  of such  data.
Pursuant  to Recital  26 information related to natural  persons is  classified
into  two  groups:  anonymous  information  and  information  concerning
an identified or identifiable natural person (i.e. personal data). Furthermore,
personal  data  which  have  undergone  pseudonymisation  should  be
considered as information on an identifiable natural person. This provision
has  been  critically  assessed  by researchers  who  used  pseudonymised
genetic  data  in their  studies  and  did  not  protect  such  data  on an equal
footing  with  personal  data,  as they  believe  it  could  have  very  negative
consequences for genetic research.40
Article 4 of the GDPR defines pseudonymisation as
“the processing of personal data in such a manner that the personal data can
no  longer  be  attributed  to a specific  data  subject  without  the use
of additional information, provided that such additional information is kept
separately and is subject to technical and organisational measures”.
39 Quinn,  P.  and Quinn,  L.  (2018)  Big genetic  data and its  big data  protection challenges.
Computer Law & Security Review, 34 (5), p. 1008.
40 Shabani, M. and Borry, P. (2018) Rules for processing genetic data for research purposes
in view  of  the  new  EU General  Data  Protection  Regulation.  European  Journal  of Human
Genetics, 26 (2), p. 151. See also: Mourby, M. et al. (2018) Are ‘pseudonymised’ data always
personal  data?  Implications  of the GDPR  for  administrative  data  research  in the UK.
Computer Law & Security Review, 34 (2), pp. 222–233.
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It  places  special  emphasis  on whether  or not  third  parties  are  able
to identify  a person  on the basis  of such  data.  In this  context,  Recital  26
states that
“to determine  whether  the person is  identifiable,  account  should be  taken
of all  the means  and  factors  reasonably  likely  to be  used  [...] to identify
the natural person directly or indirectly”,
inter alia, such factors as
“the costs of and the amount of time required for identification, taking into
consideration  the available  technology  at the time  of the processing  and
technological developments”.41
Although  similar  formulations  are  typical  of international  documents
related to the processing of genetic data,42 according to Shabani and Borry 
“the existing heterogeneity in pseudonymisation methods [...] could be seen
as a potential challenge in implementing the pertinent provisions”.43
Regarding this issue it is doubtful whether one can correctly anticipate and
take  into  account  further  technological  advances  in genetics  and
bioinformatics  in order  to draw  the objective  conclusion  as to how  much
effort and resources would be necessary to identify the person by his or her
pseudonymised  data  even  in the near  future.  That  is  why
the aforementioned provision  can be  treated as giving  the data controller
the possibility  to rely  on pseudonymisation  as a guarantee  for
the protection  of data  subject  rights,  even  when  this  procedure  is  not
justified.  Moreover,  it  is  not  clear  what  actions  should  be  taken
in a hypothetical  future  situation  in which  technological  advances  will
make  it  possible  to sharply  reduce  the time  and  effort  required  for
identification of a person by his or her pseudonymised data, given the fact
that such data will already be accessible to a wider range of persons.
41 See Recital 26 of the GDPR.
42 For  example,  the Recommendation  of the Council  of  Europe,  which  contains  a number
of special provisions on genetic data, states the following: “An individual shall not be regarded
as ‘identifiable’ if identification requires an unreasonable amount of time and manpower”. Council
of Europe.  Committee  of Ministers.  (1997)  Recommendation  No. R (97) 5  on the Protection
of Medical Data, 30 October, paragraph 1. [online] Available from: https://rm.coe.int/1680505
d5b [Accessed 7 March 2020].
43 Shabani, M. and Borry, P. (2018) Rules for processing genetic data for research purposes
in view  of the new  EU  General  Data  Protection  Regulation.  European  Journal  of Human
Genetics, 26 (2), p. 151.
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Most of these points relate equally to another kind of depersonalisation
of data,  namely,  anonymisation.  Recital  156  and  Article  89  of the GDPR
relating  to the processing  of personal  data  for  archiving  purposes
in the public interest, scientific or historical research purposes or statistical
purposes emphasize the need to ensure the principle of data minimisation.
In other words, personal data that are used for research purposes should be
limited to what is necessary in relation to the purposes for which they are
processed,  given  the obligation  to respect  the principle  of proportionality
and  taking  into  consideration  the need  to use  anonymous  information
wherever  possible.  The process  of anonymising  data  that  is  conducted
by the controller  allows  to exclude  such  data  processing  operations  from
the scope  of the GDPR  and  removes  the respective  obligations
of the controller  to the data  subject.  It  should  be  noted  that  Article  83
of the draft  Regulation  of 2012,  which  corresponds  to Article  89
of the GDPR, in fact, provided for the explicit obligation to use anonymous
information or pseudonyms for historical, statistical and scientific research
purposes whenever possible.44
The main  problem  is  that  data  anonymisation  and pseudonymisation
cannot be considered effective when it  comes to the processing of genetic
data. In particular, the Opinion 05/2014 on anonymisation techniques  adopted
by the Article 29 Working Party  draws the attention of controllers to the fact
that
“an anonymised dataset can still present residual risks to data subjects”
and emphasizes that
“anonymisation  should  not  be  regarded  as  a  one-off  exercise  and  the
attending risks should be reassessed regularly”.45
Moreover,  the Opinion  refers  to an example  of genetic  data,  which,  even
without identifiers directly related to the data subject, can be further linked
44 European  Commission.  (2012)  Proposal  for  a Regulation  of the European  Parliament  and
of the Council  on the protection  of individuals  with  regard  to the processing  of personal  data  and
on the free  movement  of such data (General  Data Protection Regulation),  COM/2012/011 final –
2012/0011  (COD),  25  January,  Article  83.  Available  from:  https://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:52012PC0011&from=EN [Accessed 9 March 2020].
45 Article  29  Data  Protection  Working  Party.  (2014)  Opinion  05/2014  on Anonymisation
Techniques, 0829/14/EN WP216, 10 April, p. 4. Available from: https://ec.europa.eu/justice/
article-29/documentation/opinion-recommendation/files/2014/wp216_en.pdf  
[Accessed 9 March 2020].
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to him or her, especially in the light of current scientific  advances.46 In this
regard, it is worth mentioning the study conducted by a team of scientists,
led  by Erlich,  a computational  geneticist  at MIT’s  Whitehead  Institute  for
Biomedical  Research,  in which  they  prove  the ability  to identify  a person
by his or her anonymised genetic data, as well as other data from publicly
available sources.47 Given current technological advances, Quinn and Quinn
argue that
“anonymisation of big genetic  research data may no longer be considered
realistic”.
They highlight three main factors making proper anonymisation elusive: 
(1) the availability of big genetic data;
(2) the ability  of researchers  to access  and  share  data  around
the world;
(3) the growth  of computational  power,  as well  as the development
of ever more sophisticated identification algorithms.
In other words, the statement “big human genetic data is always personal data”
is not far from the truth.48
The existing  EU  data  protection  legislation  does  not  give  sufficient
attention to these facts and factors. This affects the corresponding privacy
policy  of global  companies  handling  large  amounts  of genetic  data,
including  those  of EU citizens.  For  instance,  23andMe,  one of the world’s
largest  genealogy  research  services  companies,  relies  heavily  on data
anonymisation  and  pseudonymisation  as safeguards  for  the protection
of the rights and interests of data subjects when using genetic information
for  scientific  research.  But  in doing  so  the company  also  recognizes  that
though it is difficult to identify the person by his or her de-identified genetic
information,  but  not  impossible,  and  warns  about  the likelihood
of “additional risks that are currently unforeseeable”.49 Thus, given the current
46 Op. cit., p. 10.
47 Gymrek, M. et al. (2013) Identifying personal genomes by surname inference.  Science, 339,
pp. 321–324. See also: Shabani, M. and Marelli, L. (2019) Re‐identifiability of genomic data and
the GDPR:  Assessing  the re‐identifiability  of genomic  data  in light  of the EU  General  Data
Protection  Regulation.  EMBO  Rep,  20:  e48316,  5  p.  Available  from:  https://www.embo
press.org/doi/10.15252/embr.201948316 [Accessed 7 March 2020].
48 Quinn,  P.  and Quinn,  L.  (2018)  Big genetic  data and its  big data protection challenges.
Computer Law & Security Review, 34 (5), p. 1002.
49 23andMe.  (2020)  Research  Consent  Document,  paragraph  5. [online]  Available  from:
https://www.23andme.com/about/consent [Accessed 9 March 2020].
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trends in genetic technology, it cannot be argued that the GDPR establishes
the rules  for  the processing  of genetic  data  which  are  advanced  enough
to provide an adequate response to the challenges ahead.
4. RESEARCH EXEMPTION
One of the most  significant  and controversial  innovations  of the GDPR is
the introduction  of the research  exemption.  This  is  about  the relaxation
of the rules  on the handling  of personal  data,  including  derogations  from
the rights of the data subject when the processing of data is carried out
“for  archiving  purposes  in the public  interest,  scientific  or historical
research purposes or statistical purposes”.
For comparison, Directive 95/46/EC did not provide for the general research
exemption with respect to sensitive data, but member states had the right
to lay down such exemptions for reasons of substantial public interest.50
Exemptions  to the principles  of the protection  of personal  data  and
restrictions  of the rights  of the data  subject  in the interest  of science  are
found in several articles of the GDPR. In particular, Article 5 stipulates that
the further data processing is allowed for scientific research purposes and
shall  not  be  considered  as incompatible  with  the initial  purposes  (i.e. it
allows  exception  to the purpose  limitation  principle)51 and  states  that
personal data may be stored for longer periods for such purposes (exception
to the principle  of storage  limitation).52 Article  9 (2) (j)  establishes
the research  exemption  to the general  prohibition  on the processing
of special  categories  of personal  data.  Moreover,  Article  14 (5)  sets  out
an exception  to the obligation  of the data  controller  to provide  the data
subject  with  relevant  information,  where  personal  data  have  not  been
obtained from him or her, in cases where the provision of such information
would  involve  a disproportionate  effort  for  processing  for  archiving,
scientific  or historical  research  purposes.  The same  applies  to the right
of the data  subject  to have  his  or her  personal  data  erased  (“right  to be
forgotten”)  specified  in Article  17.  Article  21 (6)  allows for  the derogation
from the right to object in cases where data processing for scientific research
50 See Article 8 (4) of the Directive 95/46/EC.
51 For more on this issue, see Mészáros, J. and Ho, C. (2018) Big Data and Scientific Research:
The  Secondary  Use  of Personal  Data  under  the Research  Exemption  in the GDPR.
Hungarian Journal of Legal Studies, 59 (4), pp. 403–419.
52 See Article 5 (1) (b) and (e) of the GDPR.
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purposes is necessary for the performance of a task carried out for reasons
of public interest. Finally, under Article 89 (2), Union or member state law
may  provide  for  derogations  from  a number  of basic  rights  of the data
subject  (namely,  the right  of access,  the right  to rectification,  the right
to restriction of processing, and the right to object)
“in so far as such rights are likely to render impossible or seriously impair
the achievement of the specific purposes, and such derogations are necessary
for the fulfilment of those purposes”.
In addition, the research exemption is mentioned in several Recitals (50, 52,
53, 62, 65, and 113).53
As provided  for  in Article  89  and  Recital  156,  the legal  safeguards
protecting  personal  data  from  misuse  for  scientific  research  purposes
amount  to data  minimisation,  anonymisation,  and  pseudonymisation.
Based on the above-mentioned considerations on the effectiveness  of these
tools when it comes to the processing of genetic data, it can be concluded
that the GDPR provides favourable conditions for genetic research, while
the rights of the data subjects with regard to the processing of their genetic
data  for  scientific  research  purposes  are  threatened  and  are  not  clearly
defined. In this respect,  Pormeister  asserts that even the title of Article 89 is
somewhat misleading, because it refers to both safeguards and derogations
relating  to the processing  of personal  data  under  the research  exemption,
but
“a closer look will reveal that the referred article is more about derogations,
and less about safeguards”.54
It is worth noting that corresponding article of the draft Regulation of 2012
provided for more stringent conditions for research and relied on a rigorous
rule – “data subject’s consent or anonymisation”.55
Another important aspect refers to the definition of “scientific research”
under the GDPR. In this respect, Recital 159 stipulates that
53 In this regard, Pormeister claims that wide discretionary powers of member states to provide
derogations from a number of data protection rights lead to significant differences between
national  laws  concerning  genetic  research  and,  thus,  threaten  the interests  of both  data
subjects  and  researchers.  Pormeister,  K.  (2018)  Genetic  research  and  applicable  law:
the intra-EU  conflict  of laws  as a regulatory  challenge  to cross-border  genetic  research.
Journal of Law and the Biosciences, 5 (3), pp. 706–723.
54 Pormeister, K. (2017) Genetic data and the research exemption: is the GDPR going too far?
International Data Privacy Law, 7 (2), p. 140.
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“the processing of personal data for scientific  research purposes should be
interpreted  in a broad  manner  including  for  example  technological
development and demonstration, fundamental research, applied research and
privately funded research”.
The references to the public interest are omitted in a number of provisions
providing  the research  exemption.  This  makes  it  possible  to apply  it
to nearly all  research,  including  the one conducted solely for  commercial
purposes.
It should be noted that when drafting the GDPR, various stakeholders
drew attention to this issue. In particular, Recital 126 of the Position of the
European Parliament of 2014 with a view to the adoption of the GDPR (that
corresponds to Recital 159 of the GDPR) contained the following wording:
“The processing  of personal  data  for  historical,  statistical  and  scientific
research  purposes  should  not  result  in personal  data  being  processed  for
other  purposes,  unless  with  the consent  of the data  subject  or on the basis
of Union or Member State law”.56
The Position  paper  on the GDPR  of the Biobanking  and  BioMolecular  resources
Research Infrastructure – European Research Infrastructure Consortium stresses
the need for a clear distinction between research in the public interest and
commercially oriented research and applying the exemption only to the first
one.57 With  respect  to this  matter,  Pormeister  refers  to the Estonian
legislation  on personal  data  protection,  under  which  scientific  research
55 European  Commission.  (2012)  Proposal  for  a Regulation  of the European  Parliament  and
of the Council  on the protection  of individuals  with  regard  to the processing  of personal  data  and
on the free  movement  of such data (General  Data Protection Regulation),  COM/2012/011 final –
2012/0011  (COD),  25  January,  Article  83.  Available  from:  https://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:52012PC0011&from=EN [Accessed 9 March 2020].
56 European  Parliament  legislative  resolution  of 12  March  2014  on the proposal  for
a regulation of the European Parliament and of the Council on the protection of individuals
with  regard  to the processing  of personal  data  and  on the free  movement  of such  data
(General Data Protection Regulation). Official Journal of the European Union (2017/C-378/399)
9  November.  Available  from:  https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=
CELEX:52014AP0212&from=EN [Accessed 7 March 2020].
57 BBMRI-ERIC (Biobanking and BioMolecular resources Research Infrastructure – European
Research  Infrastructure  Consortium).  (2015)  Position  Paper  on the General  Data  Protection
Regulation,  p. 8. [online]  Available  from: https://www.bbmri-eric.eu/wp-content/uploads/
BBMRI-ERIC-Position-Paper-General-Data-Protection-Regulation-October-2015_rev1_title.
pdf [Accessed 9 March 2020]. See also: Shabani, M. and Borry, P. (2018) Rules for processing
genetic  data  for  research  purposes  in view  of the new  EU  General  Data  Protection
Regulation. European Journal of Human Genetics, 26 (2), p. 153.
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means only the one carried out by research and development institutions
excluding privately founded companies.58
On the other  hand,  it  cannot  be  argued  that  the research  exemption
established  by the GDPR  is  completely  unfounded.  It  is  usually  justified
by the arguments  arising  from  the peculiarities  of scientific  inquiry
in the fields  of genetics  and  bioinformatics.  This  refers,  for  example,
to the requirement for the publication of genetic data together with genetic
research findings in order to allow other scientists to verify the results and
to download  the data  for  their  own  further  research,  as well
as to the impossibility  of determining  ahead  of time  the exact  purpose
of genetic data processing or the duration of the research. At the same time,
the data minimisation principle is considered to be scarcely compatible with
genetic  studies,  because,  as pointed  out  by Quinn  and  Quinn,  in order
to achieve the required result scientists often need “the entire haystack to find
the needle”.59 In most cases, it is difficult to obtain the informed consent of all
data subjects whose genetic data are used by research institutions, taking
into account,  inter alia,  the unfeasibility of identifying all  those who have
undergone genetic testing and the fact that the direct identifiers associated
with  the persons  involved  have  been  removed.60 In their  privacy  policy
statements, companies that process large amounts of genetic data express
doubts about the practical applicability of many of personal data processing
rules. For instance, 23andMe provides restrictions on such rights as the right
to erasure  and  the right  to withdraw  consent.  Namely,  genetic  data  that
a customer  has  previously  provided  and  for  which  he  or she  has  given
consent  to use  in 23andMe’s  research  project  cannot  be  removed  from
ongoing or completed studies that use such information.61
The GDPR states that the
“processing of personal data should be designed to serve mankind”
58 Pormeister, K. (2017) Genetic data and the research exemption: is the GDPR going too far?
International Data Privacy Law, 7 (2), p. 145.
59 Quinn,  P.  and Quinn,  L.  (2018)  Big genetic  data and its  big data protection challenges.
Computer Law & Security Review, 34 (5), pp. 1006–1007.
60 It is worth noting once again that this does not mean that it is impossible to  identify each
individual person. Thus, the existence of such “anonymised” data creates certain risks for
data subjects.
61 23andMe.  (2020)  Research Consent  Document.  [online]  Available  from: https://www.23and
me.com/about/consent [Accessed 9 March 2020]; 23andMe. (2018)  Exercising Rights Under
the  GDPR.  Right  to Erasure  (Right  to Be  Forgotten).  [online]  Available  from:  https://perma
links.23andme.com/pdf/toolkit/erasure.pdf [Accessed 9 March 2020].
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and that the right to the protection of personal data
“must be  considered in relation to its function in society and be balanced
against  other  fundamental  rights,  in accordance  with  the principle
of proportionality”.62
Thus,  the primary  aim  of the GDPR  is  to ensure  the necessary  and
appropriate preconditions for such balancing, taking into account, inter alia,
(1) the abstract weight of each principle,
(2) the intensity of interference with them, and
(3) the reliability of the empirical assumptions.63
Regarding  the abstract  weight,  scientific  genetic  research  is,  of course,
of special importance for society. It serves the substantial public interest and
meets the legitimate expectations of society for an increase of knowledge.64
However,  the right  to the protection  of personal  data  and  the right
to privacy are important not only for a particular individual,  but also for
a society  as a whole,65 as the ensuring  of these  rights  is  an essential
condition  for  the competitive  economy,  democratic  governance  and civic
sector  development.  The extensive  research  exemption  established
by the GDPR  and  the existing  safeguards  for  the right  to the protection
of personal  data,  which  may  prove  to be  not  very  strong  and  reliable,66
make  it  look  like  the abstract  weight  of the public  interest  in scientific
research is much greater, but it is not fully justified.
Referring  to the intensity  of interference,  it  is  important  to note  that
the implementation  of an outdated  principle  “consent  or anonymisation”
would inevitably lead to a significant interference with genetic research and
would  greatly  impede  the fulfilment  of the public  interest.  However,
the current  provisions  of the GDPR  also  create  the preconditions  for
significant interference with the right to the protection of personal data, and
the situation  is  likely  to deteriorate  due  to the further  technological
62 See Recital 4 of the GDPR.
63 Alexy,  R.  (2003)  On Balancing  and  Subsumption.  A Structural  Comparison.  Ratio  Juris,
16 (4), pp. 433–449.
64 See Recital 113 of the GDPR.
65 Taylor,  M.  (2012)  Genetic  Data  and  the Law:  A Critical  Perspective  on Privacy  Protection.
Cambridge: Cambridge University Press, p. 13.
66 Staunton,  C.,  Slokenberga,  S.  and  Mascalzoni,  D.  (2019)  The GDPR  and  the research
exemption:  considerations  on the necessary  safeguards  for  research  biobanks.  European
Journal of Human Genetics, 27, pp. 1159–1167.
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developments.67 As for the reliability of the empirical assumptions, it is not
uncommon,  even  nowadays,  to find  evidence  of the uncontrolled
accumulation of genetic data, including linking them with other categories
of personal data. Given the rapid scientific and technological developments
in this  field68 and  the aforementioned  characteristics  of genetic  data,
the emergence  of new  evidence  of the interference  with  the rights
of the natural person concerning the processing of their genetic data should
be expected in the near future. 
5. CONCLUSIONS 
The emergence  of legal  norms  on the protection  of genetic  data  in the EU
legislation is  both a natural  consequence  of the progress  in biological  and
information  technologies,  which  have  caused  a marked  increase
in the processing of such data by various companies  and institutions,  and
an attempt to respond to human rights-related challenges. Most significant
developments  of the GDPR  on genetic  data  include  the clear  and
unambiguous  assignment  of such  data  to special  categories  of personal
data, the introduction of a compulsory procedure of data protection impact
assessment, and the settlement of the issue of pseudonymised data. Besides,
it  can  be  argued  that  current  EU  data  protection  legislation  creates
favourable conditions for genetic research and thus safeguards particular
public interests.
However,  the insufficient  attention  to the unique  characteristics
of genetic data distinguishing them from other categories of personal data,
which  are  already  mentioned  in several  authoritative  international
documents, can be considered as one of the main weaknesses of the GDPR.
The consequence  of this  is  the lack  of specific  regulation  establishing
a particular regime for genetic data processing appropriate to potential risks
and  threats  in this  field.  A number  of important  aspects  regarding
the processing of genetic  data, that over  the last  three decades have been
repeatedly  highlighted  by various  researchers,  experts,  and  officials,  fall
outside the scope of the GDPR. This applies primarily to the comprehensive
protection  of genetic  data  and  biological  samples,  the ensuring  of rights
67 For more on the far-reaching threats posed by big genetic data, see: Sorgner, S. L. (2017)
Genetic Privacy, Big Genetic Data, and the Internet Panopticon. Journal of Posthuman Studies,
1 (1), pp. 87–103.
68 Korf,  B.  (2013)  Genomic  privacy  in the Information  age.  Clinical  Chemistry,  59 (8),
pp. 1148–1150.
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of the persons  related  to the data  subject  (“secondary  data  subjects”),
the lack  of efficiency  of data  anonymisation  and  pseudonymisation,  etc.
The extensive research exemption together with the broadest interpretation
of scientific  research  may  lead  to significant  derogations  from  the rights
of the data subject. Under such conditions, much depends on member states
which can introduce further limitations regarding the processing of genetic
data  and  on data  controllers  that  are  to take  into  account  existing  risks
to the rights of natural persons and to implement appropriate genetic data
protection  policies.  Still,  it  cannot  substitute  for  legislative  guarantees
of the rights of data subject at the EU level.
The root  of the problem  is  that  the commonly  accepted  standards
of conducting  genetic  research  are  in many  respects  incompatible  with
the key  principles  of legislation  ensuring  privacy  and  personal  data
protection.  By adopting  the GDPR,  the European Union made an attempt
to reconcile these contradictory principles by moving beyond the previous
approach  relying  exclusively  on the data  subject’s  consent  and  data
anonymisation,  that  is  scarcely  compatible  with  contemporary  genetic
research. However, this could lead to the major imbalances between various
private and public interests.  Due to the above, the following trend can be
discerned: the control over personal information is gradually slipping away
from the data subject while the impact of genetic technology on society is
becoming more and more apparent.
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